
ISO 9001:2015
Pakistan
Quality management: consistent quality, controlled processes and continuous improvement.
A Pakistani pharmaceutical company that set out to prove quality medicine is not the preserve of multinationals.
Our story: quality medicine, made in PakistanBrowse by therapeutic area, or search the full catalogue by brand or generic name.
Miobi: multivitamin and ginseng capsulesQuality medicines for all classes of patients, made in Pakistan at prices that respect national resource constraints.
Our portfolio
We make quality medicines across a wide range of therapeutic areas, supporting healthcare professionals and patients across Pakistan.

Antibiotics in capsule, tablet and suspension form for adults and children.
Learn more
Analgesics and anti-inflammatory medicines for acute and chronic pain.
Learn more
Proton pump inhibitors for acidity, reflux and ulcers.
Learn more
Treatments for epilepsy, migraine, brain health, depression and nerve pain.
Learn more
Vitamin D, vitamin B12 and multivitamin supplements.
Learn more
Order onlineFeatured product
Red ginseng and multivitamins · Capsule, 60 capsules
Order on WhatsApp in a few taps. Your order is filled in for you.
Quality standards
We follow internationally recognised standards and run our business with integrity, accountability and uncompromising discipline.

Quality management: consistent quality, controlled processes and continuous improvement.

Environmental management: responsible operations that protect the environment.

Occupational health and safety: workplace safety, employee well-being and risk control.

Licensed manufacturer registered with the Drug Regulatory Authority of Pakistan.
Medical Updates

Chomping on vegtable skins, seeds and stalks could give us vital fibre, say food scientists.
Read on BBC (opens in a new tab)
Doctors are finding vitamin D deficiency is increasingly widespread in the UK, especially in young people. But the symptoms are difficult to spot and can be missed.
Read on BBC (opens in a new tab)
The US Department of Health and Human Services posted a draft policy that would ease restrictions about how certain peptides may be created in the United States, essentially…
Read on CNN (opens in a new tab)